Prostate carcinoma Biopsy of prostate | Radical prostatectomy Scheduled
Item
1. prostate cancer, confirmed on prostate biopsy, within two years of scheduled radical prostatectomy.
boolean
C0600139 (UMLS CUI [1,1])
C0194804 (UMLS CUI [1,2])
C0194810 (UMLS CUI [2,1])
C0205539 (UMLS CUI [2,2])
Prostate carcinoma Gleason score | Biopsy Before Radical prostatectomy
Item
2. prostate cancer must be graded as gleason 3+3 on the biopsy immediately prior to radical prostatectomy. (secondary eligibility will be established on central review of pathology slides, and blocks if available, at cornell central pathology laboratory to confirm eligibility.)
boolean
C0600139 (UMLS CUI [1,1])
C3203027 (UMLS CUI [1,2])
C0005558 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C0194810 (UMLS CUI [2,3])
Prostate carcinoma Gleason score | Biopsy Previous
Item
3. prostate cancer may have been detected on prior biopsy as well but must not be greater than gleason 3+3. (also requires central pathology laboratory review.)
boolean
C0600139 (UMLS CUI [1,1])
C3203027 (UMLS CUI [1,2])
C0005558 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
Slides Biopsy Prostate carcinoma | Blocks Formalin-fixed paraffin-embedded tissue specimen
Item
4. slides must be available for central pathology laboratory review on any biopsy showing prostate cancer. ffpe blocks may also be requested if available.
boolean
C0681504 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
C1533157 (UMLS CUI [2,1])
C2711483 (UMLS CUI [2,2])
Radical prostatectomy selected Prostate carcinoma
Item
5. patient must have selected radical prostatectomy as treatment for prostate cancer.
boolean
C0194810 (UMLS CUI [1,1])
C1707391 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
Informed Consent
Item
6. signed informed consent.
boolean
C0021430 (UMLS CUI [1])
Block Specimens Biopsy of prostate | Slides Biopsy of prostate | Block Specimens Radical prostatectomy | Slides Radical prostatectomy
Item
7. blocks and/or slides from prostate biopsy and from radical prostatectomy must be available for analysis by central pathology laboratory.
boolean
C1533157 (UMLS CUI [1,1])
C0194804 (UMLS CUI [1,2])
C0681504 (UMLS CUI [2,1])
C0194804 (UMLS CUI [2,2])
C1533157 (UMLS CUI [3,1])
C0194810 (UMLS CUI [3,2])
C0681504 (UMLS CUI [4,1])
C0194810 (UMLS CUI [4,2])
Follow-up Information Long-term
Item
8. willingness to provide long-term follow-up information regarding additional treatments and cancer status.
boolean
C3274571 (UMLS CUI [1,1])
C1533716 (UMLS CUI [1,2])
C0443252 (UMLS CUI [1,3])
Blood specimen prior to Radical prostatectomy | Urine specimen prior to Radical prostatectomy
Item
9. willingness to provide blood and urine specimens prior to radical prostatectomy for placement in the edrn upgrading reference set repository.
boolean
C0178913 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0194810 (UMLS CUI [1,3])
C1610733 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C0194810 (UMLS CUI [2,3])
Information Relationship Prostate carcinoma | Information Relationship Prostate carcinoma Risk | Ethnicity | Family history of prostate cancer
Item
10. willingness to provide demographic and clinical information related to prostate cancer and prostate cancer risk (e.g., race/ethnicity, family history of prostate cancer).
boolean
C1533716 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
C1533716 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
C0600139 (UMLS CUI [2,3])
C0035647 (UMLS CUI [2,4])
C0015031 (UMLS CUI [3])
C1532320 (UMLS CUI [4])
Gleason score Biopsy of prostate Previous
Item
1. gleason score greater than 3+3 on any prior prostate biopsy.
boolean
C3203027 (UMLS CUI [1,1])
C0194804 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
Planned Treatment Prostate carcinoma | Exception Radical prostatectomy
Item
2. any treatment other than radical prostatectomy planned for prostate cancer.
boolean
C3641097 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0194810 (UMLS CUI [2,2])
Antiandrogen therapy | Therapeutic radiology procedure | Cytotoxic Chemotherapy
Item
3. prior treatment of the prostate with androgen deprivation, radiation, or other cytotoxic chemotherapy.
boolean
C0279492 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0677881 (UMLS CUI [3])